Form 8-K - Current report:
SEC Accession No. 0001564590-20-034519
Filing Date
2020-07-30
Accepted
2020-07-30 08:01:43
Documents
13
Period of Report
2020-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K torc-8k_20200730.htm   iXBRL 8-K 40658
2 EX-99.1 torc-ex991_6.htm EX-99.1 205767
  Complete submission text file 0001564590-20-034519.txt   392709

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA torc-20200730.xsd EX-101.SCH 5780
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20200730_lab.xml EX-101.LAB 20227
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20200730_pre.xml EX-101.PRE 12087
6 EXTRACTED XBRL INSTANCE DOCUMENT torc-8k_20200730_htm.xml XML 3676
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201059279
SIC: 2834 Pharmaceutical Preparations